NO20005751L - Merkede analoger av glutamin og lysin - Google Patents

Merkede analoger av glutamin og lysin

Info

Publication number
NO20005751L
NO20005751L NO20005751A NO20005751A NO20005751L NO 20005751 L NO20005751 L NO 20005751L NO 20005751 A NO20005751 A NO 20005751A NO 20005751 A NO20005751 A NO 20005751A NO 20005751 L NO20005751 L NO 20005751L
Authority
NO
Norway
Prior art keywords
lysine
glutamine
labeled
labeled analogs
peptidases
Prior art date
Application number
NO20005751A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005751D0 (no
Inventor
Anthony Eamon Storey
Marivi Mendizabal
Susan Champion
Alex Gibson
Benedicte Guilbert
Ian Andrew Wilson
Peter Knox
Original Assignee
Nycomed Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Amersham Plc filed Critical Nycomed Amersham Plc
Publication of NO20005751D0 publication Critical patent/NO20005751D0/no
Publication of NO20005751L publication Critical patent/NO20005751L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20005751A 1998-05-15 2000-11-14 Merkede analoger av glutamin og lysin NO20005751L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98303872 1998-05-15
PCT/GB1999/001550 WO1999060018A1 (en) 1998-05-15 1999-05-14 Labelled glutamine and lysine analogues

Publications (2)

Publication Number Publication Date
NO20005751D0 NO20005751D0 (no) 2000-11-14
NO20005751L true NO20005751L (no) 2001-01-08

Family

ID=8234827

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005751A NO20005751L (no) 1998-05-15 2000-11-14 Merkede analoger av glutamin og lysin

Country Status (17)

Country Link
US (2) US7049289B1 (ko)
EP (1) EP1077998B1 (ko)
JP (2) JP4199420B2 (ko)
KR (1) KR100660509B1 (ko)
CN (2) CN1309661A (ko)
AT (1) ATE384075T1 (ko)
AU (1) AU762736B2 (ko)
BR (1) BR9910468A (ko)
CA (1) CA2332277A1 (ko)
DE (1) DE69937996T2 (ko)
ES (1) ES2299245T3 (ko)
HU (1) HUP0102154A3 (ko)
IL (1) IL139385A (ko)
NO (1) NO20005751L (ko)
RU (1) RU2205186C2 (ko)
WO (1) WO1999060018A1 (ko)
ZA (1) ZA200006313B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239655A1 (en) * 2001-01-05 2002-07-16 Duke University Contrast enhancement agent for magnetic resonance imaging
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
GB0224799D0 (en) * 2002-10-25 2002-12-04 Amersham Plc Improved complex compositions
US20070184537A1 (en) * 2003-06-03 2007-08-09 Paul Scherrer Institut Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
EP3354639B1 (en) * 2005-11-29 2024-02-21 Nihon Medi-Physics Co., Ltd. Precursor compound of radioactive halogen-labeled organic compound
WO2008060368A2 (en) * 2006-10-02 2008-05-22 Duke University Transglutaminase-binding peptides and methods of use
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
US10610608B2 (en) 2013-08-01 2020-04-07 Rochester Institute Of Technology Modular imaging agents containing amino acids and peptides
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
EP3538093B1 (en) * 2016-11-09 2023-10-25 Qiagen Sciences, LLC Photoprotective mixtures as imaging reagents in sequencing-by-synthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59186947A (ja) * 1983-03-09 1984-10-23 Kowa Co 新規ペプチド
JPH02500803A (ja) * 1987-07-07 1990-03-22 サイトアールエックス　バイオプール　リミテッド フィブリンに結合する化合物および方法
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
DE69231586T2 (de) * 1992-01-03 2001-07-19 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US6653299B1 (en) * 1997-01-21 2003-11-25 Nycomed Amersham Plc Labelled factor XIIIa substrates

Also Published As

Publication number Publication date
JP2002515510A (ja) 2002-05-28
EP1077998B1 (en) 2008-01-16
ATE384075T1 (de) 2008-02-15
US7049289B1 (en) 2006-05-23
US20060292075A1 (en) 2006-12-28
JP4199420B2 (ja) 2008-12-17
EP1077998A1 (en) 2001-02-28
HUP0102154A2 (hu) 2001-09-28
IL139385A0 (en) 2001-11-25
BR9910468A (pt) 2001-01-09
KR100660509B1 (ko) 2006-12-22
NO20005751D0 (no) 2000-11-14
RU2205186C2 (ru) 2003-05-27
CN101407543A (zh) 2009-04-15
CN1309661A (zh) 2001-08-22
AU3942899A (en) 1999-12-06
IL139385A (en) 2005-09-25
CA2332277A1 (en) 1999-11-25
DE69937996D1 (de) 2008-03-06
AU762736B2 (en) 2003-07-03
JP2006137751A (ja) 2006-06-01
HUP0102154A3 (en) 2009-01-28
DE69937996T2 (de) 2009-01-02
ZA200006313B (en) 2002-07-17
WO1999060018A1 (en) 1999-11-25
KR20010043608A (ko) 2001-05-25
ES2299245T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
MX9302876A (es) Inhibidores de doble accion.
NO20005751L (no) Merkede analoger av glutamin og lysin
NO20003018D0 (no) Triazinangiogenese-inhibitorer
DE69905476T2 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
TR200200082T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
DE60009511D1 (de) Nematizide trifluorbutene
PT1162980E (pt) Tratamento de patologias cardiovasculares e patologias relacionadas
NO20031687L (no) Veksthormonsekretagoger
DK1265606T3 (da) Celleadhæsionsinhibitorer
PT842934E (pt) Agonistas de 5-ht1f
KR970704864A (ko) 세정제 조성물
DK1273299T3 (da) Minoxidilinindeholdende praparater
NO983671D0 (no) Benzamidinderivater substituert med aminosyre- og hydroksysyrederivater, og deres anvendelse som antikoagulanter
MA26767A1 (fr) Hydroxamates de sulfonamide
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
ATE256696T1 (de) Neue cofaktoren für methyltransferasen
NO20002408L (no) 5-HT1F antagonister
ATE277018T1 (de) 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren
BR9807920A (pt) Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
DE69908940D1 (de) Substituierte dithio-bis-nitrobenzole und ihre anwendungen
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
FI911529A (fi) Halogenetylsubstituerade steroidenzyminhibitorer.
UA26428A (uk) 3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу